Prev Arrow Stocks

Elevance Health Inc. ($ELV) Stock Forecast: Down 5.9% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Elevance Health Inc.?

Elevance Health (ELV) recently shared its second-quarter earnings, reflecting the company's stock price fluctuations amid various financial factors.

Why is Elevance Health Inc. going down?

ELV stock is down 5.9% on Jul 17, 2024 19:37

  • Despite Elevance Health surpassing earnings expectations and reiterating its yearly guidance, the stock faced a downward trend.
  • Market response to indicators of escalating medical expenditures and reduced Medicaid enrollment prompted investor wariness regarding the company's future earnings.
  • The robust growth in product revenue within the Carelon sector and reduced benefit expenses were overshadowed by apprehensions about the company's financial prospects, leading to its stock decline.
  • Investors could be adopting a more cautious approach towards Elevance Health due to uncertainties concerning its profitability sustainability amidst escalating costs and membership attrition.

ELV Price Chart

ELV News

Elevance Health's ( ELV ) Q2 Earnings Beat on Lower Benefit Expense

Elevance Health's (ELV) Q2 results gain on strong product revenue growth in the Carelon business and a reduced overall expense level. Adjusted earnings are reiterated to be at a minimum of $37.20 per share in 2024.

https://www.zacks.com/stock/news/2303869/elevance-healths-elv-q2-earnings-beat-on-lower-benefit-expense

News Article Image Elevance Health's  ( ELV )  Q2 Earnings Beat on Lower Benefit Expense

Elevance Health logs $2.3 billion profit in Q2

Elevance Health''s profits in the second quarter were 24% higher than in Q2 2023, as the health insurer logged $2.3 billion in profit and $43.9 billion in revenue – the latter an improvement, but just 1% higher than the second quarter of last year.

https://www.healthcarefinancenews.com/news/elevance-health-logs-23-billion-profit-q2

News Article Image Elevance Health logs $2.3 billion profit in Q2

Elevance Health shares tumble on indication of rising medical costs

Elevance Health shares dropped on rising medical costs, forecasting lower profit.

https://seekingalpha.com/news/4125095-elevance-health-shares-tumble-on-indication-of-rising-medical-costs?feed_item_type=news

News Article Image Elevance Health shares tumble on indication of rising medical costs

Elevance Stock Slides Despite Earnings Beat as Medicaid Membership Declines

Elevance Health topped analysts'' expectations with its second-quarter results, but shares of the health insurance provider fell in intraday trading Wednesday amid "attrition in Medicaid membership."

https://www.investopedia.com/elevance-stock-slides-despite-earnings-beat-as-medicaid-membership-declines-8679215

News Article Image Elevance Stock Slides Despite Earnings Beat as Medicaid Membership Declines

Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance - Elevance Health ( NYSE:ELV )

Elevance Health Inc. ELV reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.

https://www.benzinga.com/news/earnings/24/07/39815699/elevance-health-beat-street-estimates-on-q2-profit-and-revenue-sticks-to-annual-guidance

News Article Image Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance - Elevance Health  ( NYSE:ELV )

Elevance Health Inc. Price History

17.06.2024 - ELV Stock was down 5.9%

  • Despite Elevance Health surpassing earnings expectations and reiterating its yearly guidance, the stock faced a downward trend.
  • Market response to indicators of escalating medical expenditures and reduced Medicaid enrollment prompted investor wariness regarding the company's future earnings.
  • The robust growth in product revenue within the Carelon sector and reduced benefit expenses were overshadowed by apprehensions about the company's financial prospects, leading to its stock decline.
  • Investors could be adopting a more cautious approach towards Elevance Health due to uncertainties concerning its profitability sustainability amidst escalating costs and membership attrition.

17.06.2024 - ELV Stock was down 6.0%

  • ELV stock declined despite beating earnings and revenue estimates, driven by a decrease in Medicaid membership, raising concerns about future growth.
  • Investors seemed disappointed by the slight year-over-year decline in second-quarter revenues, even though they surpassed consensus expectations.
  • The market response emphasized the focus on the Medicaid membership drop and its potential impact on the company's future, overshadowing the positive earnings beat.
  • The contrasting signals from the earnings beat and membership decline underscore the need to consider all aspects of a company's performance in evaluating stock movement.

17.06.2024 - ELV Stock was down 5.1%

  • ELV surpassed expectations for earnings and revenue in Q2 but saw a significant drop in market value.
  • The market's reaction to ELV's strong quarterly performance may be linked to concerns about its future growth potential.
  • Investor attention may have shifted to factors like guidance and general market trends, contributing to the downward trend.
  • The decrease in ELV's stock price following positive financial results could be attributed to profit-taking or broader market sentiment.

13.05.2024 - ELV Stock was up 2.0%

  • The bullish movement in ELV stock could be attributed to the positive earnings outlook projected for 2024, indicating strong growth potential for the company.
  • Investor optimism following the company's communication about their earnings outlook may have contributed to the upward movement in the stock price.
  • The market's positive reaction to the news of Elevance Health's future earnings could have driven increased buying interest and pushed the stock price higher.

31.04.2024 - ELV Stock was up 5.0%

  • ELV stock saw a bullish uptrend today, potentially due to its participation in the Goldman Sachs 45th Annual Global Healthcare Conference.
  • Being recognized as a top choice by Baird in the managed care sector, alongside other healthcare firms, might have also played a role in the positive market performance.
  • ELV's consistent long-term market outperformance, with an average annual return of 17.09% over 15 years, likely appealed to investors seeking steady growth prospects.
  • The general optimism towards healthcare stocks, reflected in Cigna Group's rising RS rating, may have additionally bolstered investor confidence in ELV's future growth potential.

31.04.2024 - ELV Stock was up 5.1%

  • Elevance Health's stock (ELV) experienced a bullish trend today, potentially influenced by its presence at a healthcare conference, showcasing its growth potential and market presence.
  • The positive sentiment around Elevance Health could also be attributed to its impressive long-term performance, with a 5.0% outperformance of the market on an annualized basis over the past 15 years.
  • Shares of U.S. health insurers, including Elevance Health, declined due to Medicaid enrollment issues faced by UnitedHealth Group, causing a temporary dip in the stock price. However, the overall bullish trend continued, supported by the company's strong fundamentals and growth prospects.

18.03.2024 - ELV Stock was up 5.8%

  • ELV reported a strong Q1 net profit of $2.2 billion, surpassing expectations despite a 21% drop in Medicaid enrollment. This positive financial performance likely boosted investor confidence and drove the bullish movement in the stock.
  • The company's decision to raise its 2024 earnings outlook also contributed to the uptrend in ELV shares, signaling a positive growth trajectory for the company.
  • Analyst projections aligning with ELV's Q1 earnings further reinforced market optimism towards the stock, attracting more investors to buy shares.
  • The overall positive earnings snapshot and beating of Q1 earnings estimates provided a solid fundamental basis for the bullish movement in ELV, reflecting the company's resilience and ability to navigate challenges in the healthcare industry.

02.03.2024 - ELV Stock was down 3.4%

  • Experienced a bearish movement today.
  • Health insurers like Elevance Health Inc and CVS Health tumbled after an announcement from the Biden Administration that final Medicare Advantage rates in 2025 won't change from initial plans.
  • The decision to cover Novo Nordisk's Wegovy by Elevance Health and CVS Health might have impacted ELV's stock negatively as investors might be concerned about the potential financial implications of covering this expensive weight loss drug.
  • The uncertainty surrounding Medicare Advantage rates and the shift in coverage policies for weight-loss drugs could have contributed to the bearish movement in ELV's stock today.

16.09.2023 - ELV Stock was up 2.6%

  • Fort Washington Investment Advisors Inc. OH reduced its position in Elevance Health, indicating a potential bearish sentiment. However, this did not impact the overall bullish movement of the stock.
  • Carson Advisory Inc. made a new investment in Elevance Health, suggesting a positive outlook for the stock.
  • Elevance Health experienced a slight increase in its stock price, indicating market resilience despite a dip in the overall market.
  • The decline in Medicare Advantage star ratings for Elevance Health may have impacted payments and rebates, but it did not hinder the overall bullish movement of the stock.

14.06.2023 - ELV Stock was up 5.1%

  • Wolfe Research downgraded Elevance Health from Outperform to Peer Perform, which caused a decline in the stock price.
  • However, despite the downgrade, the stock received a moderate buy consensus rating.
  • Unusual options activity suggests that a large investor has taken a bullish stance on Elevance Health.
  • The stock's earnings are expected to grow, which could be a positive factor contributing to the bullish movement.

12.06.2023 - ELV Stock was down 3.3%

  • ELV's stock price has been affected by uncertainties in the health industry and bond market, as mentioned in an article from Seeking Alpha.
  • The bearish movement could also be influenced by the news of a data breach at HCA Healthcare, a medical giant that operates hospitals in the U.S. and Britain. The breach, which may have affected 11 million patients, could have created concerns about data security and potential financial implications for healthcare companies like ELV.
  • The breach, although not directly related to ELV, could have raised concerns about the overall vulnerability of healthcare companies to cyber attacks and data breaches, leading to a negative sentiment in the market for ELV.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.